Sexually low performing male rats die earlier than their high performing peers and (-)deprenyl treatment eliminates this difference
- 31 December 1994
- journal article
- Published by Elsevier in Life Sciences
- Vol. 54 (15) , 1047-1057
- https://doi.org/10.1016/0024-3205(94)00415-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- Pharmacological basis of the therapeutic effect of (−)deprenyl in age‐related neurological diseasesMedicinal Research Reviews, 1992
- (-)Deprenyl-Medication: A Strategy To Modulate the Age-Related Decline of the Striatal Dopaminergic SystemJournal of the American Geriatrics Society, 1992
- The Pharmacological Profile of (–)Deprenyl (Selegiline) and its Relevance for Humans: A Personal ViewBasic & Clinical Pharmacology & Toxicology, 1992
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- The pharmacology of selegiline ((−)deprenyl). New aspectsActa Neurologica Scandinavica, 1989
- The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's DiseaseScience, 1989
- The striatal dopamine dependency of life span in male rats. Longevity study with (−)deprenylMechanisms of Ageing and Development, 1988
- Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm studyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- The facilitation of dopaminergic activity in the aged brain by (−)deprenyl. A proposal for a strategy to improve the quality of life in senescenceMechanisms of Ageing and Development, 1985